JAZZ - Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q2 2020 Results - Earnings Call Transcript
Jazz Pharmaceuticals plc (JAZZ)
Q2 2020 Earnings Conference Call
August 4, 2020 4:30 P.M. ET
Company Participants
Kathy Littrell - Head of Investor Relations
Bruce Cozadd - Chief Executive Officer
Renee Gala - Chief Financial Officer
Dan Swisher - President
Rob Iannone - Executive Vice President, R&D
Kim Sablich - Executive Vice President, General Manager, North America
Jed Black - Senior Vice President, Sleep and Neuroscience
Conference Call Participants
Brandon Folkes - Cantor Fitzgerald
Umer Raffat - Evercore
Gary Nachman - BMO Capital Markets
David Amsellem - Piper Sandler
Ami Fadia - SVB Leerink
Andrew